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Abstract
Objective. The aim of this study was to evaluate the presence of digital lesions in very early diagnosis of
SSc (VEDOSS) patients and its possible association with internal organ involvement.
Methods. One hundred and ten VEDOSS patients were investigated for the presence of digital ulcers
(DUs), digital pitting scars, calcinosis, necrosis or gangrene, nailfold videocapillaroscopic abnormalities,
disease-specific autoantibodies (ACA and anti-topo I) and internal organ involvement.
Results. Four patients reported a history of digital pitting scars, while 25 patients presented an active DU
or reported a history of DUs. In particular, 16 patients presented with active DUs (14/16 also reporting a
history of previous DUs), while the other 9 patients reported a history of DUs only. A statistically significant
association between DUs and oesophageal manometry alteration was found in the whole DU population,
as well as in the history of DU and the presence of active DU with/without a history of DU subgroups
(P< 0.01, P= 0.01 and P<0.05, respectively). DUs were observed in VEDOSS patients with internal organ
involvement but not in those without organ involvement.
Conclusion. DUs are already present in VEDOSS patients characterized by internal organ involvement,
significantly correlating and associating with gastrointestinal involvement. DUs may be a sentinel sign for
early organ involvement in VEDOSS patients.
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Introduction
SSc is a major challenge for the rheumatologist, as its
diagnosis is difficult in the very early/early phase of the
disease [1]. For this reason, great interest is devoted
today to patients with very early diagnosis of SSc
(VEDOSS), when the degree of vasculopathy and fibrosis
still have a minimal clinical impact [2]. The diagnosis of
very early SSc is highly suspected in the presence of
the so called red flags: RP, puffy fingers and ANA. The
suspicion is then confirmed by the positivity of either ACA
or anti-topo I positivity and/or a nailfold videocapillaro-
scopy (NVC) scleroderma pattern [2].
Usually in established SSc, one of the main vascular
complications is digital ulcers (DUs) [3], which are a
significant burden to SSc patients [4]. Therefore the prob-
lem of DUs has been considered as a clinical priority and
randomized clinical trials have been designed to prevent
and heal DUs [5]. In SSc, DUs appear early [6], may sig-
nificantly lower the patient’s quality of life and may be a
harbinger of a poorer prognosis [7, 8]. For this reason, the
prompt identification and management of DUs is manda-
tory. The aim of the present study was to evaluate whether
in VEDOSS patients digital lesions, and in particular DUs,
could be detected early and whether their presence is
associated with internal organ involvement [7].
Methods
In the VEDOSS Clinic of the Department of Clinical and
Experimental Medicine, Section of Rheumatology,
Azienda Ospedaliero Universitaria Careggi (AOUC) of the
University of Florence, 316 RP patients were enrolled in
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the VEDOSS study from March 2010 to May 2012. These
patients are part of a larger cohort of patients involved
in the multicentre VEDOSS study [9]: 110 patients were
classified as VEDOSS according to the presence of pre-
liminary criteria (RP, puffy fingers, ANA, plus NVC
abnormalities and/or disease-specific antibodies) [2].
Other causes of digital vasculopathy, such as diabetes,
cryoglobulinaemia, arterial hypertension and haematolo-
gical diseases, were ruled out and smoking history was
reported by 17% of the population. NVC was performed
by trained physicians (C.B., G.L.) and images were clas-
sified into scleroderma patterns (early, active or late) ac-
cording to the methodology and previously proposed
classification [10]. In every patient, demographic data
[age, sex, disease duration (defined as the time since
RP onset)] were recorded during the first visit. The follow-
ing signs and symptoms were investigated: presence of
active DUs or a history of DUs as previously defined by
Amanzi et al. [4], oesophageal symptoms (heartburn and
dysphagia), digital numbness (median nerve compres-
sion), dyspnoea, pitting scars, calcinosis and tel-
angiectases and modified Rodnan skin score. All 110
patients were investigated for internal organ involvement,
such as interstitial lung disease (ground glass, reticular or
honeycombing pattern of pulmonary fibrosis), on chest
high-resolution CT (HRCT), impairment of pulmonary
function tests with/without a reduction in the diffusion
capacity of carbon monoxide (DLCO) and a dysfunctional
oesophageal lower sphincter on oesophageal manometry
(with basal low pressure <15 mmHg). Ethics approval was
obtained from the Bioethical Committee of the AOUC of
Florence, Italy. All participants provided written informed
consent to participate in the study. Statistical analysis
were performed using SPSS Statistics version 19 (IBM,
Armonk, NY, USA) through chi-squared and Fisher’s
exact tests to test the association between binomial vari-
ables, while the MannWhitney U test was used to com-
pare continuous variables.
Results
Clinical characteristics of the VEDOSS patients
ACA was positive in 59/110 patients, while anti-topo I
positivity was found in 21/110 patients. NVC showed a
scleroderma pattern in 80/110 patients (50/80 early and
30/80 active pattern). In the cohort of 110 VEDOSS pa-
tients, only 4 patients [3.6%; 4 female, mean age 52 years
(S.D. 11)] reported a history of digital pitting scars; 25 pa-
tients [23%; 22 female and 3 male, mean age 51.5 years
(S.D. 13.8), mean time from RP onset 9.2 years (S.D. 6.3)]
presented a DU or reported a history of previous DUs. In
particular, 16 patients [15%; 13 female and 3 male, mean
age 47.4 (S.D. 9.5), mean time from RP onset 8.9 years (S.D.
6.2)] had active DUs at the moment of first presentation to
our centre or during follow-up visits. The majority of these
patients (14/16) also reported a history of previous DUs.
Another nine patients [8%; 9 females, mean age 58.6
years (S.D. 17.7), mean time from RP onset 9.6 years
(S.D. 6.9)] reported a history of DUs only. No patient
showed or reported the presence of tissue necrosis, gan-
grene or calcinosis. Patient characteristics are shown in
Table 1.
VEDOSS patients with DUs
In the group of 25 patients with DUs and/or a history of
DUs, ACA/anti-topo I were detected in 17 patients, while
an early NVC pattern was detected in 19 and an active
NVC scleroderma pattern was seen in 5. These two NVC
SSc patterns were more frequently seen in patients with
a DU (96%) compared with those without a history nor
present DUs (66%), showing a statistically significant
association with presence/history of DU (P< 0.01), in par-
ticular regarding the early scleroderma pattern (P< 0.01).
Telangiectases were also associated with DUs (P< 0.05),
as a possible other manifestation of generalized vasculo-
pathy. There were trends of longer disease duration and
higher frequency of anti-topo I antibodies in patients with
DUs (P= 0.09 and P= 0.15, respectively).
Internal organ involvement
Patients with a history of or present DUs had a higher
frequency of oesophageal manometry abnormalities only
(21/25, 84%, P< 0.01). When patients with history of DUs
and patients with active DUs were compared with patients
without DUs, this association remained significant
(P= 0.01 and P< 0.05, respectively). The whole cohort of
110 patients was then divided into four groups according
to the presence of pulmonary involvement (pulmonary
fibrosis or ground glass areas on chest HRCT with or with-
out a reduction of DLCO <80%) and/or gastrointestinal
involvement (dysfunctional oesophageal lower sphincter
on manometry with basal low pressure <15 mmHg) as fol-
lows: patients without gastrointestinal or pulmonary in-
volvement (23/110, 20.9%), patients with pulmonary
involvement but without gastrointestinal disease (27/110,
24.5%), patients with gastrointestinal involvement but
without pulmonary disease (30/110, 27.3%) and patients
with gastrointestinal and pulmonary involvement (30/110,
27.3%) [11]. DUs were not seen in the group without
internal involvement, while they were present in the
second (4/27, 14.8%), third (13/30, 43.3%) and fourth
groups (8/30, 26.6%). In addition, DUs showed a statis-
tically significant association and correlation with gastro-
intestinal involvement (P< 0.01; see Table 2).
Discussion
It is well known that behind RP there frequently hides SSc
and therefore a thorough internal organ investigation is
mandatory [11]. This single-centre study identifies a
large cohort of VEDOSS patients in which DUs and
asymptomatic or subclinical involvement of the lung
and/or gastrointestinal systems are already present. The
results are in line with previous studies, confirming not
only that early internal organ involvement can be detected
in very early SSc patients [7, 12], but also that its preva-
lence is comparable to what was reported for established
SSc patients in a recent meta-analysis [13]. Furthermore,
www.rheumatology.oxfordjournals.org 73
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our data show that DUs are already present in those
VEDOSS patients who already show asymptomatic or
subclinical oesophageal and/or lung involvement.
The detection of DUs in VEDOSS patients suggests that
microvascular abnormalities are already prominent before
the fibrotic features of SSc-related cutaneous, gastro-
intestinal and pulmonary involvement become symptom-
atic and clinically evident [12, 14]. In our VEDOSS
population, a significant association was seen between
DUs and anti-topo I autoantibodies, but not between
DUs and ACA. This result is partially concordant with pre-
vious published data on established SSc patients [15, 16].
Regarding NVC, it is interesting to note that in our single-
centre study, no patient with a DU showed a late sclero-
derma pattern, which is more frequently associated with
the presence of peripheral vascular lesions in established
SSc patients [1719]. The evidence that a large number of
VEDOSS patients develop internal organ involvement
strongly suggests that these patients can be classified
as already in an early phase of the disease, despite the
TABLE 1 Characteristics of the VEDOSS patients included in this study
(A) No DUs
(n=85)
(B) History
of DUs (n=9)
(C) Active DUs
(n=16)
P-value P-value P-value
A vs (B +C) B vs (A +C) C vs (A +B)
Age, mean (S.D.),
yearsa
50.9 (16.4) 58.6 (17.7) 47.4 (9.5) 0.87 0.13 0.99
Disease duration,
mean (S.D.), yearsa
7.1 (7) 9.6 (6.9) 8.9 (6.2) 0.18 0.35 0.39
Male, n (%)b 6 (7) 0 (0) 3 (19) 0.68 >0.99 0.13
ACAb 44 (52) 4 (44) 11 (63) 0.50 0.73 0.28
SCL70b 19 (22) 2 (22) 0 (0) 0.15 0.68 <0.05
U1RNPb 3 (4) 0 (0) 0 (0) >0.99 NA NA
PM-Sclb 1 (1) 0 (0) 0 (0) >0.99 NA NA
Oesophageal
symptomsb
40 (47) 5 (56) 10 (63) 0.36 >0.99 0.41
Numbnessb 15 (18) 8 (22) 4 (25) 0.56 0.68 0.50
Dyspnoeab 11 (13) 1 (11) 1 (6) 0.73 >0.99 0.68
Telangiectasesb 3 (4) 3 (33) 2 (13) <0.05 <0.05 0.33
ILD on HRCTb 27 (32) 5 (56) 7 (44) 0.16 0.27 0.57
DLCO< 80%
b 36 (42) 6 (67) 9 (56) 0.17 0.29 0.43
Abnormal oesophageal
manometryb
39 (46) 9 (100) 12 (75) <0.01 0.01 <0.05
NVC normalb 29 (34) 0 (0) 1 (6) <0.01 NA 0.11
NVC early patternb 31 (37) 8 (89) 11 (69) <0.01 <0.05 0.06
NVC active patternb 25 (29) 1 (11) 4 (25) 0.32 0.27 0.77
NVC late patternb 0 (0) 0 (0) 0 (0) NA NA NA
VEDOSS: very early SSc; DUs: digital ulcers; SCL70: anti-topo I antibody; U1RNP: anti-ribonucleoprotein U1; PM-Scl:
anti-PM-Scl antibody; ILD: interstitial lung disease; HRCT: high-resolution CT; DLCO: diffusion capacity of carbon monoxide;
NVC: nailfold videocapillaroscopy; NA: not applicable. aMannWhitney U-test. bValues given as n (%). Prevalence
determined by chi-square test with Fisher’s exact test when appropriate. Values in bold are statistically significant with
P< 0.05.
TABLE 2 Risk of organ involvement in patients with DUs
DUs
(n=25), n (%)
No DUs
(n=285), n (%)
Relative
risk P-valuea
No organ involvement 0 (0) 23 (27) 0.00 <0.01
Gastrointestinal involvement only 13 (52) 17 (20) 2.60 <0.01
Pulmonary involvement only 4 (16) 23 (27) 0.59 0.30
Gastrointestinal and pulmonary involvement 8 (32) 22 (26) 1.23 0.61
aDU vs no DU, chi-squared or Fisher’s test when appropriate. Values in bold are statistically significant with
P< 0.05. DU: digital ulcers.
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absence of skin tightness, as previously defined by our
group [1]. The small number of VEDOSS patients without
internal organ involvement may represent a limitation in
this study. However, the fact that DUs are absent in pa-
tients classified as VEDOSS without organ involvement
but present in patients with gastrointestinal and/or lung
involvement suggests that DUs may be considered, in
some cases, a sentinel sign for evolution from very early
to early SSc with internal organ involvement (dysfunctional
lower oesophageal sphincter, ground glass on HRCT,
DLCO reduction on pulmonary function tests) [1].
In conclusion, while RP remains the main clinical senti-
nel sign for the suspicion of very early SSc [2, 11], our data
suggest that in VEDOSS patients DUs may serve as a
clinical sentinel sign of possible internal organ involve-
ment, characterizing evolution to early SSc [1]. It remains
to be evaluated how much the new ACR/European
League Against Rheumatism (EULAR) criteria will modify
the approach to the very early and early diagnosis of SSc
now that fingertip ulcers have been added as a classifica-
tion criterion [20]. It is interesting to note that 44% of the
VEDOSS population already fulfil the new 2013 ACR/
EULAR classification criteria [9] and further evaluation of
and attention to the presence of DUs could improve our
ability to diagnose patients as SSc, especially for those
patients without a positive disease-specific antibody.
However, the VEDOSS study, characterized by diagnostic
and not classification criteria, will help determine on a
larger number of patients the real position of DUs in the
identification of very early SSc and internal organ
involvement.
Rheumatology key messages
. Digital ulcers are a major complication in SSc, even
in very early and early disease.
. The presence of digital ulcers in very early SSc pa-
tients should raise suspicion of internal organ
involvement.
Funding: None.
Disclosure statement: The authors have declared no
conflicts of interest.
References
1 Matucci-Cerinic M, Bellando-Randone S, Lepri G, Bruni C,
Guiducci S. Very early versus early disease: the evolving
definition of the ‘many faces’ of systemic sclerosis. Ann
Rheum Dis 2013;72:31921.
2 Avouac J, Fransen J, Walker UA et al. Preliminary criteria
for the very early diagnosis of systemic sclerosis: results of
a Delphi Consensus Study from EULAR Scleroderma
Trials and Research Group. Ann Rheum Dis 2011;70:
47681.
3 Steen V, Denton CP, Pope JE, Matucci-Cerinic M. Digital
ulcers: overt vascular disease in systemic sclerosis.
Rheumatology 2009;(Suppl 3):iii1924.
4 Amanzi L, Braschi F, Fiori G et al. Digital ulcers in sclero-
derma: staging, characteristics and sub-setting through
observation of 1614 digital lesions. Rheumatology 2010;
49:137482.
5 Matucci-Cerinic M, Denton CP, Furst DE et al.
Bosentan treatment of digital ulcers related to systemic
sclerosis: results from the RAPIDS-2 randomised, double-
blind, placebo-controlled trial. Ann Rheum Dis 2011;70:
328.
6 Hachulla E, Clerson P, Launay D et al. Natural history of
ischemic digital ulcers in systemic sclerosis: single-center
retrospective longitudinal study. J Rheumatol 2007;34:
242330.
7 Valentini G, Vettori S, Cuomo G et al. Early systemic
sclerosis: short-term disease evolution and factors pre-
dicting the development of new manifestations of organ
involvement. Arthritis Res Ther 2012;14:R188.
8 Mouthon L, Mestre-Stanislas C, Be´rezne´ A et al. Impact
of digital ulcers on disability and health-related quality
of life in systemic sclerosis. Ann Rheum Dis 2010;69:
2147.
9 Minier T, Guiducci S, Bellando-Randone S et al.
Preliminary analysis of the Very Early Diagnosis of
Systemic Sclerosis (VEDOSS) EUSTAR multicentre study:
evidence for puffy fingers as pivotal sign for the suspi-
cion of systemic sclerosis. Ann Rheum Dis 2013 Aug 12.
doi: 10.1136/annrheumdis-2013-203716 [Epub ahead of
print].
10 Cutolo M, Pizzorni C, Sulli A. Nailfold videocapillaroscopy
assessment of microvascular damage in systemic scler-
osis. J Rheumatol 2000;27:15560.
11 Czirjak L, Matucci-Cerinic M. Beyond Raynaud’s phe-
nomenon hides a very early systemic sclerosis: the as-
sessment of organ involvement is always mandatory.
Rheumatology 2011;50:2501.
12 Lepri G, Bellando-Randone S, Guiducci S et al. Evidence
for oesophageal and anorectal involvement in patients
with very early diagnosis of systemic sclerosis (VEDOSS):
report from a single VEDOSS/EUSTAR centre. Ann Rheum
Dis 2014 Jan 28. doi: 10.1136/annrheumdis-2013-203889
[Epub ahead of print].
13 Muangchan C, Canadian Scleroderma Research Group.
In: Baron M, Pope J. The 15% rule in scleroderma: the
frequency of severe organ complications in systemic
sclerosis. A systematic review. J Rheumatol 2013;40:
154556.
14 Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evi-
dence that systemic sclerosis is a vascular disease.
Arthritis Rheum 2013;65:195362.
15 Khimdas S, Harding S, Bonner A et al. Associations with
digital ulcers in a large cohort of systemic sclerosis: results
from the Canadian Scleroderma Research Group registry.
Arthritis Care Res 2011;63:1429.
16 Denton CP, Krieg T, Guillevin L et al. Demographic, clinical
and antibody characteristics of patients with digital ulcers
in systemic sclerosis: data from the DUO Registry. Ann
Rheum Dis 2012;71:71821.
17 Lambova S, Mu¨ller-Ladner U. Capillaroscopic findings in
systemic sclerosis—are they associated with disease
duration and presence of digital ulcers? Discov Med 2011;
12:4138.
www.rheumatology.oxfordjournals.org 75
Digital ulcers in early SSc
Downloaded from https://academic.oup.com/rheumatology/article-abstract/54/1/72/1840562
by UNIVERSITA DI FIRENZE DIPARTIMENTO DI PEDIATRIA user
on 28 August 2018
18 Smith V, Riccieri V, Pizzorni C et al. Nailfold capillaro-
scopy for prediction of novel future severe organ in-
volvement in systemic sclerosis. J Rheumatol 2013;40:
20238.
19 Ennis H, Moore T, Murray A, Vail A, Herrick AL. Further
confirmation that digital ulcers are associated with the
severity of abnormality on nailfold capillaroscopy in pa-
tients with systemic sclerosis. Rheumatology 2014;53:
3767.
20 Van den Hoogen F, Khanna D, Fransen J et al. 2013
classification criteria for systemic sclerosis: An American
College of Rheumatology/European League Against
Rheumatism collaborative initiative. Ann Rheum Dis 2013;
72:174755.
Clinical vignette
Rheumatology 2015;54:76
doi:10.1093/rheumatology/keu370
Advance Access publication 18 September 2014
MRI myositis sine myositis: the importance of the
histopathology
SIR, A 67-year-old woman complained of painful, swollen
ankles that limited weight bearing. Serum inflammatory
markers were increased. A US ruled out joint effusion.
The MRI scan (Fig. 1, left; coronal and axial views)
revealed increased signal intensity in T2 fat-saturated se-
quences involving both leg muscles diffusely, characteris-
tic of myositis. However, there were no proximal muscle
symptoms and creatine kinase (CK) levels were normal.
A muscle biopsy was performed (Fig. 1, right; haematox-
ylin and eosin stain). Remarkably, the muscle fibres
showed no necrosis, atrophy or inflammation within the
endomysium or in the perifascicular compartment.
Conversely, marked inflammatory infiltrates involved the
medium to small vessels with fibrinoid necrosis and
lumen obliteration; no giant cells or granuloma were pre-
sent. These findings were consistent with PAN.
MRI muscle oedema may be the result of inflammatory
myopathies, infections, trauma, muscle infarction or de-
nervation [1]. Vasculitis is not usually included in the dif-
ferential diagnosis, making histopathological confirmation
essential. PAN restricted to the lower limbs was reported
to show a focal, patchy muscle involvement on the
MRI [2], whereas in our case the oedema was diffuse
(myositis-like). The absence of muscle fibre necrosis in
the biopsy explained both the normal CK levels and the
preserved strength.
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FIG. 1 MRI and biopsy findings of PAN limited to lower limbs
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